Next Article in Journal
Hypertension Prevalence Based on Blood Pressure Measurements on Two vs. One Visits: A Community-Based Screening Programme and a Narrative Review
Previous Article in Journal
Corona-Triggered Global Macroeconomic Crisis of the Early 2020s
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Two-Source Capture-Recapture Method to Estimate the Incidence of Acute Flaccid Paralysis in the Marches Region (Italy)

by
Pamela Barbadoro
1,2,*,
Aurora Luciani
1,
Matteo Ciotti
1,
Marcello Mario D’Errico
1,2 and
on behalf of the AFP Working Collaborative Group
3,†
1
Department of Biomedical Science and Public Health, Università Politecnica delle Marche, via Tronto 10/A, 6, 60121 Ancona, Italy
2
Infection Control Unit, AOU Ospedali Riuniti di Ancona, via Conca, 60126 Torrette di Ancona, Italy
3
School of Hygiene and Preventive Medicine, Department of Biomedical Science and Public Health, Università Politecnica delle Marche, via Tronto 10/A, 6, 60121 Ancona, Italy
*
Author to whom correspondence should be addressed.
AFP Working Collaborative Group: Anna Marigliano, Antonella D’Alleva, Claudia Recanatini, Marina Di Vincenzo, Jacopo Dolcini, Lara Rita Napolitano, Valerio Pasquale Di Buono, Marco Lombardi.
Int. J. Environ. Res. Public Health 2020, 17(24), 9400; https://doi.org/10.3390/ijerph17249400
Submission received: 15 September 2020 / Revised: 28 November 2020 / Accepted: 28 November 2020 / Published: 15 December 2020

Abstract

:
A combination of high infant immunization coverage and surveillance of acute flaccid paralysis (AFP) cases, plays a critical role in polio eradication. This study aimed to estimate the incidence of AFP, to evaluate the completeness of AFP ascertainment during the years, age groups and gender, and to define the main associated diagnosis among children aged under 15 in the Marches region of Italy. Analysis was performed on data from the active AFP surveillance system and the hospital discharge records in the 2006–2014 period. The two-source capture-recapture method was applied. After cross-validation, 30 AFP compatible conditions as defined by the WHO were identified, with an incidence estimate of 1.91 cases of AFP per 100,000 children under 15 years (95% CI = 1.4–2.6/100,000). Guillain–Barrè syndrome was the most common diagnosis. A significant difference (p < 0.05) has been registered in the estimated probability of case ascertainment in females. The reasons for the lower reporting of cases in females are unknown. Specific research and the implementation of a more sensitive surveillance system are essential in verifying potential inequalities and to succeed in the polio eradication initiative.

1. Introduction

In May 1988, the World Health Assembly launched the Global Polio Eradication Initiative (GPEI) aimed to achieve the goal of global eradication of poliomyelitis by 2000. The goal was defined as no cases of clinical poliomyelitis associated with wild poliovirus and no wild poliovirus found worldwide. The strategy subsequently adopted by the World Health Organization (WHO) relies on four key strategies: high infant immunization coverage, mass campaigns, active surveillance for wild poliovirus and target “mop up” campaigns [1,2].
Europe has been declared polio free since 2002. In Italy the last case of poliomyelitis due to transmission of indigenous wild poliovirus occurred in 1982 [3]. In 2018 polio was still declared a Public Health Emergency of International Concern (PHEIC) by the WHO due to Poliovirus (PV) reintroduction through populations movements, such as cross border spreading in both direction from Pakistan to Afghanistan [4]. However, the WHO has highlighted that it has been four years since there was any international spread of wild types of poliovirus (WPV) outside of these two epidemiologically linked countries [5,6]. Since then, in order to detect any virus importation, a reinforcement of PV surveillance was encouraged everywhere to prevent the risk that international spread may go undetected [5,6,7]. Therefore, in polio-free countries it is important to guarantee high quality surveillance until polio is eradicated globally, to prevent the risk of importation of cases from areas where the disease is still endemic [8,9,10],
Active surveillance for acute flaccid paralysis (AFP) is considered a very sensitive system to rapidly detect, report and investigate confirmed poliomyelitis cases. In countries in polio-free regions, AFP surveillance should be evaluated through indicators, such as by sensitivity of surveillance and completeness of case investigation [11]. Indeed, the number of cases reported every year is used as an indicator of a country’s ability to detect polio, even in polio-free countries.
The incidence in any population of AFP cases due to conditions other than polio (the non-polio AFP rate) is estimated to be one case per 100,000 children aged under 15 years [11]. A country’s surveillance system should be sensitive enough to detect at least 1 case of AFP for every 100,000 children aged under 15, even in the absence of polio. Also, a surveillance system should ensure the completeness of case investigation. GPEI suggests that all AFP cases should have a full investigation (virologic and clinical) with at least 80% of AFP cases having “adequate” stool specimens collected [11]. In 2017, the Italian Ministry of Health declared that AFP surveillance had shown different critical aspects, including the under-notification of cases (estimated to be from 20% to 60%), estimated through the comparison between the notified data from the national AFP surveillance and the data the hospital discharge records (HDRs).
The aims of this study were to estimate the incidence of AFP, to evaluate the completeness of AFP ascertainment by year, age groups and gender, and to define the main associated diagnosis among children aged under 15 in the Marches Region of Italy.

2. Methods

2.1. Organization of AFP Surveillance in Italy

In Italy, the surveillance of AFP was extended to a national level in 1997 and carried out by the National Institute of Health (ISS) and the Ministry of Health (MOH) through 20 Regional Reference Centres (RRCs). An AFP case is defined as a child aged under 15 showing clinical acute onset of flaccid paralysis in one or more limbs, or acute onset of bulbar paralysis [12].
Clinical samples (consisting of two stool specimens and one sample of serum) are sought for each case and sent to the ISS for virologic investigations. After case notification, a follow-up questionnaire is required to be sent to the ISS and MOH to determine whether residual paralysis or death occurred 60–90 days after diagnosis, as well as to clarify the conclusive diagnoses. Virologic investigations are usually performed by ISS [13].

2.2. Organization of AFP Surveillance at the Regional Level

The Chair of Hygiene at the Polytechnic University of the Marche is the RRC for the same region. The Marches are one of the twenty regions of Italy. The name of the region derives from the plural name of marca, originally referring to the medieval March of Ancona and to the nearby marches of Camerino and Fermo, representing its cross-border nature. The region is located in the Central area of the country on the Adriatic Sea, and has about 1.5 million inhabitants. On a two-weeks basis designated staff contacts by phone the reference doctors of 25 Operative Units (15 of pediatrics, 3 of infectious diseases, 7 of neurology/child neuropsychiatry) belonging to the network. For every AFP case the management is activated according to the directives of the ISS and MOH.

2.3. Data Sources and Diseases under Study

The study was carried out retrospectively with data from 2006 to 2014. The primary data source was the regional database of AFP cases originating from notifications by phone to the RRC of Marche. The secondary data source comprised hospital discharge records (HDRs) including a diagnosis consistent with AFP-compatible conditions as defined by the WHO. Characteristics of paralytic polio are fever at onset, asymmetric flaccid paralysis, rapid progression of paralysis, residual paralysis after 60 days and preservation of sensory nerve function. The most common differential diagnoses of AFP include Guillain-Barré syndrome, paralytic poliomyelitis, and transverse myelitis [14]. Therefore, the study focused on 29 diagnostic ICD-9 codes (main or secondary) listed in Appendix A. We analyzed only the AFP cases occurring in children aged <15 years and the HDRs belonging to ordinary hospitalization in the same period by the same hospitals involved in surveillance.
The authorization from the local Ethics Committee was not required, as the program belongs to a national ministerial project considering the WHO directives for the achievement of the poliomyelitis eradication (WHA 41.28 of May 1988). Research carried out on humans was performed in compliance with the Helsinki Declaration.
The two-source capture-recapture method was used to assess the incidence of AFP cases, the sensitivity of the surveillance system to detect all AFP cases and the completeness of case investigation [15,16,17,18]. Hospital records were linked to the regional database of notifications. The likelihood of association between two records was based on a core set of identifiers (age, sex of the patient, and month and year of notification or hospital admission). Linked cases were allocated to the year of the first known date of notification or hospital admission (in case of absence of a notification) and laboratory culture confirmation date (for notified cases). Estimates were stratified by year of diagnosis, age group (0–3 years, 4–7 years, 8–11 years, and 12–15 years), ICD9-CM diagnosis code, and gender. The sensitivity of the system was defined as the number of notified cases divided by the total number of cases as estimated by the capture-recapture method.
In this study we compared cases from two sources to estimate the total number of cases, based on Formula (1):
N = ab/c
where N is the total number of cases, a is the total number of cases determined from the primary source (regional database of AFP cases notified in Marches), b is the total number of cases ascertained from the secondary source (hospital discharge records) and c is the number of cases established by both sources. In the present study, the number of AFP estimated cases has been calculated using the Chapman modification to the Lincoln–Petersen estimator for the capture-recapture method, as follows (2):
N = [(a + 1)(b + 1)/(c + 1)] − 1
Estimated completeness was calculated based on Formula (3):
d = a/N × 100
where d is the estimated completeness, a is the total number of cases determined from the primary source (regional database of AFP cases notified in Marches), and N is the total number of estimated cases. The difference between ascertained/estimated number of events has been assessed by the chi-squared test. The 95% CI for the population size was calculated using the ciChapman function from the recapr package, with the default bootstrap method. Analyses were performed with the r software. [19] The level of significance was set at 0.05.

3. Results

The regional database of AFP cases notified to the RRC included information about six AFP cases in the 2010–2014 period, equivalent to an annual incidence of 0.54 per 100,000 children aged under 15 years (95% CI = 0.25–1.86/100,000). According to the recommended WHO target level, a minimum of 11 cases should have been recorded in the target population. Patients discharged with AFP-compatible diagnoses identified from the hospital discharge records led to 30 cases of hospitalization with an incidence estimate of 2.72/100,000 (95% CI = 1.90–3.88/100,000). The estimated completeness of ascertainment by the ongoing surveillance system was therefore 14.15% (95% CI = 6.65–27.6, Table 1).
The average annual incidence of AFP, based on the capture-recapture method (Table 1), was estimated at 3.84 per 100,000 children under 15 years (95% CI = 2.84–5.19/100,000), with 3.69 cases/100,000 males <15 years old (95% CI = 3.47–7.35/100,000), and an annual incidence rate of 5.05/100,000 in females (95% CI = 2.41–5.64/100,000). A significant difference (p < 0.05) was calculated in the estimated probability of case ascertainment in females; in fact, only 3.7% (N = 1) of estimated cases have been ascertained in the surveillance system versus 23.8% (N = 5) of cases in males.
Considering all cases with a hospital admission, 70% (N = 21) had the 357.0 ICD-9-CM diagnosis code, which is used for “acute infective polyneuritis”, such as Guillain-Barré syndrome, 16.7% of patients (N = 5) had the 344.89 code, that is applied for “other specified paralytic syndrome” (es. flaccid paralysis), while 13% of them (N = 4) had the 341.22 code for “acute (transverse) myelitis NOS”.

4. Discussion

The results of the study show that routine surveillance by phone achieved an estimated 14.15% completeness of ascertainment, with an incidence estimate of 0.54 per 100,000, that does not reach the WHO target of 1 per 100,000 cases in children aged under 15 years. An increase in AFP ascertainment was obtained using HDRs, achieving an estimated 85.85% completeness of ascertainment, equivalent to an incidence estimate of 2.72/100,000 children under 15 years. These results are clearly less satisfactory than those recently reported from Egypt [20].
The two-source capture-recapture method led to an estimated average annual incidence of AFP of 3.84 per 100,000 children under 15 years of age. This value exceeds the WHO target and the incidence estimated by a previous study in the same region performed by using surveillance data alone but is in line with recent national estimates including the evaluation of HDR [8,21].
The capture-recapture method allows the estimation of the total size of a population by crossing different sources; it represents a helpful tool for estimating frequency, with an easy application and simple principles of calculation. However, there are conditions which must be satisfied to obtain accuracy and appropriateness of results. For example, one condition is that all the cases identified by each source are real. All the cases in the regional database of AFP are real and notified according to the WHO case definition established. In some cases, the identification of cases by HDRs can be difficult and challenging for the lack of a well-established specific definition [21]; in addition, procedures for coding data may differ between wards, potentially leading to an error in estimates [22]. However, the comparison of the two sources may be important to reduce this potential error. The sensitivity of the system may be even further improved through a “zero reporting system” or an e-mail reminder) to implement a more sensitive surveillance system, which also includes an environmental monitoring of the waste water, as reiterated in numerous and recent scientific evidences [23,24]. To note, the reasons for the estimated higher incidence of reporting AFP cases among males are unknown, but this finding might be related to either reporting biases or the presence of underlying factors, and has been recently registered in other international contexts [25,26,27,28]. This result is even more important as the estimated incidence rates among females and males do not differ significantly. However, besides using capture-recapture designs which have been frequently applied to assess the total case population of health conditions using different sources, we must underline the possible limitation of the above finding. In fact, to be valid, the capture-recapture methods need some assumptions: the study of a closed population; ability to perfectly match cases captured in both methods (in both methods, perfect classification); within a method, any has case equal probability of being captured; and independence of capture between the different surveillance systems [18].
The Lincoln–Petersen estimator may be biased at small sample sizes, like that used in this study. An alternative for small numbers is given by the Chapman estimator. One of the main limitations of this method is the assumption of independence between the two sources. In fact, it is known that with increasing dependencies between sources the Lincoln–Petersen/Chapman estimator will underestimate the population size; on the other hand, decreased dependencies will potentially overestimate a population size. Chao proposed an alternative estimator of population size which relaxes the assumption that identifying sources are independent; moreover Chao’s estimator has been shown to be more viable than Chapman’s estimator, and therefore should be carefully considered, especially in the context of dependency between sources [29,30,31]. In the present study we can assume that the two sources were quite independent; in fact, the routine notification system relied on paediatricians, regardless of the practice setting, while the HDR data were largely the responsibility of hospital medical or nursing staff. Moreover, all cases had an equal, a priori, probability of inclusion, given the absence of any theoretical barrier to the accessibility of hospital and community healthcare services in Italy. We think that cases had accurately been identified and linked and that appropriate matching occurred between sources. In fact, given the relatively limited number of observations, authors have been able to check the linkage between the two sources on a one-by-one basis; ambiguous results have been discussed and reviewed. However, we should consider that bias would have been reinforced if any of these assumptions were invalid.

5. Conclusions

During the reporting period, the notification system has not always reached the recommended notification target rate. Indeed, in the last 3 years examined (from 2012 to 2014), no case of AFP was notified by the phone surveillance. These results highlight the lack of exhaustiveness of the notification system in identifying AFP in children under 15 years and highlight the need for a change in the process.
Vaccine-preventable diseases continue to pose a great risk to the community and the hospital setting. [29,30] Knowledge of signs and symptoms, awareness of outbreaks in-community and elsewhere, and early consultation with an expert in infectious diseases and public health authorities in suspected cases, are key preventive care measures [32,33,34,35].
Moreover, enhancing the surveillance system will be a key to achieve a prompt identification of viruses potentially causing serious disease in the community.
Surveillance has been supported by the Italian National Institute of Health.

Author Contributions

Conceptualization, P.B. and M.M.D.; methodology, P.B. and M.M.D.; validation, M.M.D. and P.B.; formal analysis, P.B., A.L. and M.C.; investigation, A.L., M.C. and P.B.; data curation, P.B., A.L., M.C. and AFP Working Collaborative Group; writing—original draft preparation, P.B., A.L. and M.C.; writing—review and editing, P.B.; supervision, M.M.D.; project administration, M.M.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Table A1. List of diagnostic ICD-9 codes compatible with diagnosis of AFP.
Table A1. List of diagnostic ICD-9 codes compatible with diagnosis of AFP.
ICD-9-CM Diagnosis CodeDiagnosis
357.0Acute infective polyneuritis (includes Guillain-Barré syndrome)
045.0Acute paralytic poliomyelitis specified as bulbar
045.00Acute paralytic poliomyelitis specified as bulbar, poliovirus, unspecified type
045.01Acute paralytic poliomyelitis specified as bulbar, poliovirus type I
045.02Acute paralytic poliomyelitis specified as bulbar, poliovirus type II
045.03Acute paralytic poliomyelitis specified as bulbar, poliovirus type III
045.1Acute poliomyelitis with other paralysis
045.10Acute poliomyelitis with other paralysis, poliovirus, unspecified type
045.11Acute poliomyelitis with other paralysis, poliovirus type I
045.12Acute poliomyelitis with other paralysis, poliovirus type II
045.13Acute poliomyelitis with other paralysis, poliovirus type III
045.2Acute nonparalytic poliomyelitis
045.20Acute nonparalytic poliomyelitis, poliovirus, unspecified type
045.21Acute nonparalytic poliomyelitis, poliovirus type I
045.22Acute nonparalytic poliomyelitis, poliovirus type II
045.23Acute nonparalytic poliomyelitis, poliovirus type III
045.9Unspecified acute poliomyelitis
045.90Acute poliomyelitis, unspecified, poliovirus, unspecified type
045.91Acute poliomyelitis, unspecified, poliovirus type I
045.92Acute poliomyelitis, unspecified, poliovirus type II
045.93Acute poliomyelitis, unspecified, poliovirus type III
341.2Acute (transverse) myelitis
341.20Acute (transverse) myelitis Not Otherwise Specified (NOS)
341.21Acute (transverse) myelitis in conditions classified elsewhere
341.22Idiopathic transverse myelitis
344.89Other specified paralytic syndrome (includes flaccid paralysis)

References

  1. World Health Organization Regional Office for Europe. Guidelines on Responding to the Detection of Wild Poliovirus in the WHO European Region; World Health Organization Regional Office for Europe: Copenhagen, Denmark, 2007. [Google Scholar]
  2. World Health Organization. Polio: The Beginning of the End; World Health Organization: Geneva, Switzerland, 1997. [Google Scholar]
  3. World Health Organization Regional Office for Europe. Fifteenth Meeting of the Regional Commission for the Certification of Poliomyelitis Eradication; World Health Organization Regional Office for Europe: Copenhagen, Denmark, 2002. [Google Scholar]
  4. Eurosurveillance Editorial Team. WHO declares international spread of wild poliovirus a public health emergency of international concern. Eurosurveill 2014, 1919, 20798. [Google Scholar]
  5. World Health Organization. Statement of the Nineteenth IHR Emergency Committee Regarding the International Spread of Poliovirus. Available online: https://www.who.int/news-room/detail/30-11-2018-statement-of-the-nineteenth-ihr-emergency-committee-regarding-the-international-spread-of-poliovirus (accessed on 16 July 2019).
  6. World Health Organization. Statement of the Twenty-Third IHR Emergency Committee Regarding the International Spread of Poliovirus. Available online: https://www.who.int/news-room/detail/07-01-2020-statement-o-the-twenty-third-ihr-emergency-committee-regarding-the-international-spread-of-poliovirus (accessed on 7 January 2020).
  7. Pellegrinelli, L.; Bubba, L.; Primache, V.; Pariani, E.; Battistone, A.; Delogu, R.; Fiore, S.; Binda, S. Surveillance of poliomyelitis in Northern Italy: Results of acute flaccid paralysis surveillance and environmental surveillance, 2012–2015. Hum. Vaccines Immunother. 2017, 13, 332–338. [Google Scholar] [CrossRef] [PubMed]
  8. D’Errico, M.M.; Barbadoro, P.; Bacelli, S.; Esposto, E.; Moroni, V.; Scaccia, F.; Tantucci, L.; Prospero, E.; Group, A.S. Surveillance of acute flaccid paralysis in the Marches region (Italy): 1997–2007. BMC Infect. Dis. 2008, 8, 135. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Martin, N.; Paterson, J.; Durrheim, D.N. Australia’s Polio Risk. Commun. Dis. Intell. Q. Rep. 2014, 30, E107–E113. [Google Scholar]
  10. Tegegne, A.A.; Braka, F.; Shebeshi, M.E.; Aregay, A.K.; Beyene, B.; Mersha, A.M.; Ademe, M.; Muhyadin, A.; Jima, D.; Wyessa, A.B. Characteristics of Wild Polio Virus Outbreak Investigation and Response in Ethiopia in 2013–2014: Implications for Prevention of Outbreaks Due to Importations. BMC Infect. Dis. 2018, 18, 9. [Google Scholar] [CrossRef] [Green Version]
  11. World Health Organization. Best Practices in Active Surveillance for Polio Eradication; World Health Organization: Geneva, Switzerland, 2018. [Google Scholar]
  12. Fiore, L.; Novello, F.; Simeoni, P.; Amato, C.; Vellucci, L.; De Stefano, D.; Grandolfo, M.E.; Luzzi, I. Surveillance of acute flaccid paralysis in Italy 1996–1997. Eur. J. Epidemiol. 1999, 15, 757–763. [Google Scholar] [CrossRef]
  13. Pellegrinelli, L.; Primache, V.; Fiore, L.; Amato, C.; Fiore, S.; Bubba, L.; Pariani, E.; Amendola, A.; Barbi, M.; Binda, S. Surveillance of acute flaccid paralysis (AFP) in Lombardy, Northern Italy, from 1997 to 2011 in the context of the national AFP surveillance system. Hum. Vaccines Immunother. 2015, 11, 277–281. [Google Scholar] [CrossRef] [Green Version]
  14. Marx, A.; Glass, D.; Sutter, R.W. Differential Diagnosis of Acute Flaccid Paralisis and its Role in Poliomyelitis Surveillance. Epidemiol. Rev. 2000, 22, 298–316. [Google Scholar] [CrossRef] [Green Version]
  15. Hook, E.B.; Regal, R.R. Capture-recapture methods in epidemiology: Methods and limitations. Epidemiol. Rev. 1995, 17, 243–264. [Google Scholar] [CrossRef]
  16. Brenner, H. Use and Limitations of Capture-Recapture Method in Disease Monitoring with Two Independent Sources. Epidemiology 1995, 6, 42–48. [Google Scholar] [CrossRef]
  17. Tilling, K. Capture-recapture methods—Useful or misleading? Int. J. Epidemiol. 2001, 30, 12–14. [Google Scholar] [CrossRef] [PubMed]
  18. Whitfield, K.; Kelly, H. Using the two-source capture–recapture method to estimate the incidence of acute flaccid paralysis in Victoria, Australia. Bull. World Health Organ. 2002, 8080, 846–851. [Google Scholar]
  19. In Recapr: Estimating, Testing, and Simulating Abundance in a Mark-Recapture. R Package Version 0.3.9002. 2016. Available online: https://rdrr.io/github/mbtyers/recapr/ (accessed on 1 July 2020).
  20. Abdel-Fattah, A.; El-Gilany, A.; El-Masry, R.; Kanddeel, A. Acute flaccid paralysis in North East Delta, Egypt: A retrospective analysis of prospectively collected surveillance data. J. Infect. Public Health 2019, 12, 714–719. [Google Scholar] [CrossRef] [PubMed]
  21. Stefanelli, P.; Bellino, S.; Fiore, S.; Fontana, S.; Amato, C.; Buttinelli, G. The Regional Reference Centres. Hospital discharges-based search of acute flaccid paralysis cases 2007–2016 in Italy and comparison with the National Surveillance System for monitoring the risk of polio reintroduction. BMC Public Health 2019, 1, 1532. [Google Scholar]
  22. Lugardon, S.; Desboeuf, K.; Fernet, P.; Montastruc, J.-L.; Lapeyre-Mestre, M. Using a capture–recapture method to assess the frequency of adverse drug reactions in a French university hospital. Br. J. Clin. Pharmacol. 2006, 6262, 225–231. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Matrajt, G.; Naughton, B.; Bandyopadhyay, A.; Meschk, J. A Review of the Most Commonly Used Methods for Sample Collection in Environmental Surveillance of Poliovirus. Clin. Infect. Dis. 2018, 67 (Suppl. 1), S90–S97. [Google Scholar] [CrossRef] [Green Version]
  24. Duintjer Tebbens, R.; Zimmermann, M.; Pallansch, M.; Thompson, K. Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems. Food Environ. Virol. 2017, 99, 361–382. [Google Scholar] [CrossRef]
  25. World Health Organization. Taking Sex and Gender into Account in Emerging Infectious Disease Programs; World Health Organization: Geneva, Switzerland, 2011. [Google Scholar]
  26. Guerra-Silveira Felipe, A.-F.F. Sex Bias in Infectious Disease Epidemiology: Patterns and Processes. PLoS ONE 2013, 8, e62390. [Google Scholar] [CrossRef] [Green Version]
  27. Muenchhoff, M.; Goulder, P.J.R. Sex differences in pediatric infectious diseases. J. Infect. Dis. 2014, 209, S120–S126. [Google Scholar] [CrossRef] [Green Version]
  28. Piccini, P.; Montagnani, C.; de Martino, M. Gender disparity in pediatrics: A review of the current literature. Ital. J. Paediatr. 2018, 44, 1. [Google Scholar] [CrossRef]
  29. Brittain, S.; Böhning, D. Estimators in capture–recapture studies with two sources. Adv. Stat. Anal. 2009, 93, 23–47. [Google Scholar] [CrossRef]
  30. Chao, A. Estimating population size for sparse data in capture–recapture experiments. Biometrics 1989, 45, 427–438. [Google Scholar] [CrossRef]
  31. Chao, A.; Tsay, P.K.; Lin, S.H.; Shau, W.Y.; Chao, D.Y. Tutorial in Biostatistics: The applications of capture–recapture models to epidemiological data. Stat. Med. 2001, 20, 3123–3157. [Google Scholar] [CrossRef] [PubMed]
  32. Barbadoro, P.; Marigliano, A.; Di Tondo, E.; De Paolis, M.; Martini, E.; Prospero, E.; D’Errico, M.M. Measles among healthcare workers in a teaching hospital in central Italy. J. Occup. Health 2012, 54, 336–339. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Costantino, C.; Ledda, C.; Genovese, C.; Contrino, E.; Vitale, E.; Maida, C.M.; Squeri, R.; Vitale, F.; Rapisarda, V. Immunization Status against Measles of Health-Care Workers Operating at Three Sicilian University Hospitals: An Observational Study. Vaccines 2019, 7, 175. [Google Scholar] [CrossRef] [Green Version]
  34. Lo Vecchio, A.; Montagnani, C.; Krzysztofiak, A. Measles outbreak in a High Income Country: Are Pediatricians Ready? J. Pediatric Infect. Dis. Soc. 2019, 9, 416–420. [Google Scholar] [CrossRef]
  35. Desai, S.; MacDonald, N. Vaccine-preventable diseases: Uncommon disease primer for the front-line provider. Paediatr. Child. Health 2019, 2424, 130. [Google Scholar] [CrossRef]
Table 1. Crude and stratified analysis by year of acute flaccid paralysis (AFP) ascertainment: cases ascertained (notified and in hospital discharge records HDRs) and estimated total cases.
Table 1. Crude and stratified analysis by year of acute flaccid paralysis (AFP) ascertainment: cases ascertained (notified and in hospital discharge records HDRs) and estimated total cases.
Notified Cases (Primary Source) (a)AFP Cases in HDRs (Secondary Source) (b)Total Observed Cases by Both Sources (c)Estimated Total Number of Cases (N)Estimated Completeness of AFP Surveillance System (d = a/N × 100)Estimated Incidence from the Capture-Recapture Method per 100,000 Children under 15
Year
201004040.001.81 (95% CI = 0.70–4.66)
20115931435.716.3 (95% CI = 3.75–10.58)
2012161616.671.81 (95% CI = 0.70–4.66)
201307070.003.18 (95% CI = 1.55–6.56)
201404040.001.82 (95% CI = 0.71–4.67)
Age group
0–3 years31421915.796.83 (95% CI = 4.37–10.67)
4–7 years352742.862.52 (95% CI = 1.22–5.19)
8–11 years03030.001.10 (95% CI = 0.37–3.22)
12–15 years08080.002.92 (95% CI = 1.48–5.76)
Sex
Females1130273.75.05 (95% CI = 3.47–7.35)
Males51742123.83.69 (95% CI = 2.41–5.64)
Total63043716.24.40 (95% CI = 3.18–5.77)
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Barbadoro, P.; Luciani, A.; Ciotti, M.; D’Errico, M.M.; on behalf of the AFP Working Collaborative Group. Two-Source Capture-Recapture Method to Estimate the Incidence of Acute Flaccid Paralysis in the Marches Region (Italy). Int. J. Environ. Res. Public Health 2020, 17, 9400. https://doi.org/10.3390/ijerph17249400

AMA Style

Barbadoro P, Luciani A, Ciotti M, D’Errico MM, on behalf of the AFP Working Collaborative Group. Two-Source Capture-Recapture Method to Estimate the Incidence of Acute Flaccid Paralysis in the Marches Region (Italy). International Journal of Environmental Research and Public Health. 2020; 17(24):9400. https://doi.org/10.3390/ijerph17249400

Chicago/Turabian Style

Barbadoro, Pamela, Aurora Luciani, Matteo Ciotti, Marcello Mario D’Errico, and on behalf of the AFP Working Collaborative Group. 2020. "Two-Source Capture-Recapture Method to Estimate the Incidence of Acute Flaccid Paralysis in the Marches Region (Italy)" International Journal of Environmental Research and Public Health 17, no. 24: 9400. https://doi.org/10.3390/ijerph17249400

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop